Search results

Order by most recent / most popular / relevance

Results: 1-10 of 30

Putative class alleges pharma statements about new drug violated securities laws

Shook Hardy & Bacon LLP
-
USA
-
May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

Genetic technologies settles infringement suit over non-DNA coding technology

Shook Hardy & Bacon LLP
-
USA
-
May 2 2013

Genetic Technologies Ltd. (GTG) has reportedly settled a patent infringement lawsuit filed in late 2012 against PreventionGenetics. While the terms

SCOTUS hears arguments on patentability of human genes

Shook Hardy & Bacon LLP
-
USA
-
April 18 2013

The U.S. Supreme Court (SCOTUS) heard arguments on Monday specifically addressing whether "human genes are patentable." Ass'n for Molecular Pathology

Ninth Circuit to consider impact of trial court error in admitting expert testimony

Shook Hardy & Bacon LLP
-
USA
-
April 4 2013

In related cases that could have implications for intellectual property, consumer safety and complex litigation where resolution of the dispute

Amici add briefs on “pay-for-delay” issue to SCOTUS docket

Shook Hardy & Bacon LLP
-
USA
-
February 8 2013

As oral argument nears in a case before the U.S. Supreme Court addressing whether payments made to generic drug makers who agree to delay entry into

SCOTUS refuses to hear challenge to government stem cell research funding

Shook Hardy & Bacon LLP
-
USA
-
January 10 2013

The U.S. Supreme Court (SCOTUS) has rejected a request that it review a D.C. Circuit Court of Appeals ruling dismissing a challenge to government funding

Federal court denies HHS motion to seal documents in medical-device whistleblower

Shook Hardy & Bacon LLP
-
USA
-
January 10 2013

A federal court in the District of Columbia has denied the government's request to seal an exhibit in Freedom of Information Act litigation over records

U.S. Supreme Court to consider just one question in Myriad Genetics

Shook Hardy & Bacon LLP
-
USA
-
December 6 2012

The U.S. Supreme Court has agreed to review a Federal Circuit Court of Appeals ruling on the patentability of human genes and limited its grant of certiorari to the question “Are human genes patentable?”

CRS visiting scholar recommends that Congress clarify patentable subject matter doctrine

Shook Hardy & Bacon LLP
-
USA
-
November 15 2012

In a Congressional Research Service paper titled “Mayo v. Prometheus: Implications for Patents, Biotechnology, and Personalized Medicine,” visiting scholar John Thomas considers how the U.S. Supreme Court ruling limiting the patentability of diagnostic methods that simply describe natural phenomena and relations may affect innovation and public health

Federal Circuit’s patent infringement ruling conflicts with USPTO re-examination on validity

Shook Hardy & Bacon LLP
-
USA
-
November 1 2012

The Federal Circuit Court of Appeals has denied a request for an en banc rehearing by a medical-device patent holder which argued that the U.S. Patent and Trademark Office’s (USPTO’s) Board of Patent Appeals had effectively nullified a previous Federal Circuit decision on the validity of its patent

next >